versus in Medical News

Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results

... income in the second quarter was $411 million, versus $499 million in the second quarter of last year. ... second quarter net income was $620 million, versus $351 million in the second quarter of last year. ... net income was approximately $1.1 billion, versus net income of $601 million in the same period ...

Hill-Rom Reports Third Quarter Financial Results

... Revenue of $335 million declined 8.8 percent versus prior year and was stable to last quarter ... share from continuing operations were $0.25 versus $0.34 in prior year (which included $0.12 in ... flow was $61 million, an increase of $58 million versus prior year Cash position up $44 ...

Smart Balance Announces 2009 Second Quarter Results

... net sales of $58.2 million, an increase of 21.2% versus year ago, and earnings per share of $0.02, versus a loss of $0.02 per share in 2008. The second quarter net sales increase versus 2008 was due to a 13% volume growth in case ...

SXC Health solutions announces record second quarter financial results

... 2009: - Revenue of $1.35-$1.4 billion versus prior estimate of $1.25-$1.35 billion - Gross profit of $166-$171 million versus prior estimate of $145-$155 million - ... amortization) of $1.42-$1.50 versus prior estimate of $0.93-$1.01 - Adjusted ...

Clarient Reports Second Quarter Revenue Up 40 Percent

... in revenue for the second quarter of 2009 versus the second quarter of 2008, and a 43 percent increase in revenue for this year's first six months versus the first six months of 2008. Second ... June 30, 2009, operating income was $2.3 million versus an operating loss of $1.9 million for the six ...

Innophos Holdings, Inc. Reports Second Quarter 2009 Results

... million, a decrease of $58.6 million, or 65.1%, versus $90.0 million for the comparable period in 2008. ... was $3.6 million, a decrease of $4.8 million versus $8.4 million for the comparable period in 2008. ... was $10.7 million, a decrease of $12.0 million versus $22.7 million for the comparable period in 2008. ...

Antidepressant Use in U.S. Has Almost Doubled

... use were seen in blacks (3.61 percent in 1996 versus 4.51 percent in 2005) and in Hispanics (3.72 percent versus 5.21 percent in 2005), the researchers found. ... treated for depression (26.25 percent in 1996 versus 26.85 percent in 2005), indicating that the drugs ...

STAAR Surgical Generates Cash From Operations During Second Quarter

... units grew 29% during the second quarter of 2009 versus the second quarter of 2008. Sequentially, global ... of international currencies, primarily the Euro, versus the dollar. U.S. Visian ICL units were down 18% during the second quarter versus an estimated 45% decline in LASIK procedures in ...

Fox Chase researchers identify differences in treatments and outcomes of patients with second primary lung cancers versus those with one primary lung cancer

... of lung cancer. When diagnosed with OPLC versus SPLC, localized disease was 45% versus 60%, loco-regional disease was 35% versus 32%, and metastatic disease was ...

Advanced targeted therapies effective as first-line treatment for lung cancer

... patients can receive treatment in-home versus in a hospital setting, easing the burden on ... survival among patients with an EGFR mutation versus those without. "Our findings show that ... not get larger) was 40.8 percent with erlotinib versus 27.4 percent with placebo. The study also met a ...

HMS Holdings Corp. Announces Q2 2009 Results and Raises 2009 Guidance

... for the quarter increased 32.7% to $16.4 million versus $12.4 million for the same period a year ago. ... 2009, revenue increased 24.8% to $103.8 million versus $83.1 million for the prior year. Net income for ... half was $12.3 million or $0.45 per diluted share versus net income of $8.2 million or $0.31 per diluted ...

AMERIGROUP Reports Q2 Net Income of $49.6 Million or $0.94 per Diluted Share, Including $0.43 per Diluted Share Positive Impact from Tax Adjustment

... was $49.6 million, or $0.94 per diluted share, versus a loss of $164.0 million, or $3.10 per diluted ... been $27.2 million, or $0.51 per diluted share, versus second quarter 2008 net income of $35.2 million, ... income and other revenues were $6.5 million versus $18.5 million in the second quarter of 2008 and ...

Medifast Reports Record Second Quarter 2009 Financial Results

... EPS for the quarter increased 82% to $0.20 versus $0.11 year-over-year; Direct sales segment, ... response revenue-to-spend ratio improves to 2.7 versus 2.5 a year ago; Operating margins improve to 11.8% versus 8.7% in the comparable quarter; Free Cash ...

AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer

... of vandetanib 100mg once daily plus docetaxel versus docetaxel alone in patients with locally advanced ... combination of vandetanib 100mg with pemetrexed versus pemetrexed alone in patients with locally ... ZEST ( Z ACTIMA E fficacy S tudy versus T arceva) is a Phase III randomised, ...

Gentiva Reports Second Quarter 2009 Results

... improved to 11.9% in the second quarter of 2009 versus 9.2% in the prior-year period. EBITDA included ... 2009: Net revenues of $587.0 million versus $665.8 million in the prior year period. Net ... EBITDA increased 15% to $63.6 million versus $55.3 million in the prior-year period. ...

Michigan IT Companies Helping the University of Miami Center for Patient Safety Tackle a Leading Cause of Death Using an RTLS Solution to Monitor Staff Hand-Washing Compliance

... in Farmington Hills, Mich. Traverse City -based versus Technology designed the automatic HHC system ... of our patients. That's why we are working with versus and DCC to create an exciting, ... Tenarvitz, Chief Intellectual Property Officer of versus agrees, "It is very important ...

Grupo Casa Saba Announces Quarterly Earnings Report 2Q09

... were 7.73% - Operating income increased 2.75% versus 2Q08 - The operating margin for the quarter ... Sales for this division reached $6,457.01 million versus $5,825.07 million in 2Q08 and represented 85.20% ... reached $653.26 million, an increase of 1.93% versus the $640.89 million registered during the second ...

Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29

... the second quarter of 2009 to $3,713 million versus $3,764 million in the second quarter of 2008. ... the second quarter of 2009, relatively unchanged versus $2,843 million in the second quarter of 2008. ... sales decreased 6 percent to $801 million versus $849 million for the second quarter of 2008. The ...

Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance

... items, decreased 9% for the 2009 second quarter versus the 2008 second quarter and decreased 4%, ... items, increased 7% for the 2009 second quarter versus the 2008 second quarter and increased 8%, ... items, decreased 7% for the 2009 first half versus the 2008 first half and were comparable to the ...

-Contrave(R) Obesity Research Phase 3 Program Meets Co-Primary and Key Secondary Endpoints; Exceeds FDA Efficacy Benchmark for Obesity Treatments-

... and efficacy of Contrave16 and Contrave32 versus placebo in 1,742 obese patients. This trial ... tolerability and efficacy of Contrave32 versus placebo in 1,496 obese patients. After week ... tolerability and efficacy of Contrave32 versus placebo in 505 obese patients with type 2 ...

Vein Removal Method Linked to Bypass Results

... the greater rate of graft failure (46.7 percent versus 38 percent at 18 months), death or heart attack (9.3 percent versus 7.6 percent at three years) and deaths (7.4 percent versus 5.8 percent at three years) seen in those who had ...

Versus Technology, Inc. Partners With Microsoft(R) To Promote Health Care Automation in Windows 7 Computing Environments

... CITY, Mich., July 15 /PRNewswire-FirstCall/ -- versus Technology, Inc. (Versus) is pleased to announce ... 2009 Worldwide Partner Conference. The versus Real-Time Locating Solution (RTLS) will be ... interaction and discharge, in part utilizing the versus infrared (IR) and RFID automated patient tracking ...

Study finds survival rates from gastrointestinal tumors improving among African-Americans

... was higher in African Americans (0.56 percent versus 0.76 percent Caucasians, p=0.012). After 2000, ... was equivalent between races (0.46 percent versus 0.35 percent for Caucasians, p=0.517). Before ... Caucasians than African Americans (79.3 percent versus 75.1 percent, p=0.025). There was no racial ...

Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII

... study investigating the efficacy of prophylactic versus on-demand rFVIII-FS treatment In another ... bleeds per 6-month treatment period (zero events versus 15.0 events, respectively; P<0.001) and improved median total Gilbert Scores (18 versus 25, respectively; P<0.001) compared with ...

Versus Technology, Inc. Announces Sale of Real-Time Location System to the St. Louis VA Medical Center

... real-time location information system (RTLS) from versus Technology, Inc. (Versus) to improve efficiency ... room for automated patient tracking. The versus RTLS, used in hundreds of healthcare facilities ... events, alerts and automatic data collection. versus will provide real-time data on key performance ...

New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%

... prebiotics had an 80% survival rate to 24 months versus a 50% survival rate for the control group rats ... reductions in cholesterol and body weight versus the control group. Significantly, the ... has repeatedly shown synergistic health benefits versus the more common single-prebiotic fibers such as ...

Major study highlights weight differences among 3-19 year-olds with type 1 and 2 diabetes

... likely to be overweight/obese than females (34% versus 27%) while females were more likely to be overweight/obese when they were 12-19 years of age (37% versus 29%). African American females were ... in both age groups than males (54/55% versus 36/36%) but there were no significant differences ...

Forest Laboratories Announces Positive Top-line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community-acquired Bacterial Pneumonia (CABP) Requiring Hospitalization

... In FOCUS II, the respective rates were 82.1% versus 77.2% (95% CI: -2.5, 12.5). For the MITT, the respective rates in FOCUS I were 83.8% versus 77.7% (95% CI: -0.2, 12.6) and in FOCUS II were 81.3% versus 75.5% (95% CI: -1.0, 12.7). According to the ...

Boston Scientific's Urology/Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting

... data comparing the benefits of experienced-based versus evidence-based outcomes for patients treated with ... Randomized Clinical Trial of Trans-Obturator Tape versus Tension-Free Vaginal Tape Procedure for the ... will discuss the benefits of experienced-based versus evidence-based clinical data. Presenters will ...

Study finds air traffic control tracking method reduces errors in trauma management

... in critical patient data (99 percent correct versus 87 percent correct, p=0.017). Additionally, the ... better tracked mechanism of injury (100 percent versus 88 percent, p=0.004), working diagnosis (100 percent versus 93 percent, p=0.045) and disposition of patients ...

Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis-C Virus (HCV)

... DFPP treatment provided an average SVR of 71.4% versus the 51% previously referenced in Telaprevir ... capture HCV and immunosuppressive proteins versus the indiscriminate removal of particles by DFPP. ... is one single-use disposable cartridge versus the requirement for two cartridges and multiple ...

Versus Introduces Automated, Real-Time Hand Hygiene Compliance Solution

... capture only 0.12% of hand washing opportunities. versus Technology, Inc. has introduced a Hand Hygiene ... The Hand Hygiene Compliance Solution from versus includes unique Infrared (IR) and RFID badges for ... receives an audible acknowledgement that the versus system has captured this HHC event. The event is ...

Versus Technology, Inc. Announces Sale of Real-Time Location Information System to the Chalmers P. Wylie Veterans Clinic

... CITY, Mich., June 2 /PRNewswire-FirstCall/ -- versus Technology, Inc. (Pink Sheets: VSTI) (Versus) ... staff in over 150 separate room areas. The versus system, using safe infrared (IR) and radio ... on locations and interactions with key staff. The versus RTLiS has been deployed at hundreds of acute care ...

Drug Trials Show Modest Gains Against Lung Cancer

... overall survival in those taking pemetrexed versus 10.3 months for those taking a placebo. ... a median progression-free survival of 17.3 weeks versus 14 weeks for those taking the placebo, a 21 ... significant: 10.6 months in the Zactima arm versus 10 months in the placebo group," said Herbst, who ...

Versus Technology, Inc. Announces Spring '09 Release for Added Workflow Automation

... improve patient flow and perfect communication. versus Technology, Inc. is the only real-time location ... system (RTLS) company meeting these needs. versus is focused on helping hospitals and clinics be ... Solutions to the healthcare industry. The versus Spring '09 Release, featuring enhanced real-time ...

Versus Technology Announces Second Quarter Results

... to the same quarter of the prior year. versus reported a net loss of $407,000 for the current ... consolidated financial statements. About versus Technology, Inc. versus Technology, Inc. is the leader in the development ...

Perforomist Inhalation Solution data to be presented today at American Thoracic Society conference

... (shortness of breath) and rescue medication use versus treatment with tiotropium alone. In a second ... in patients with moderate to severe COPD versus treatment with tiotropium alone. This data ... by 192 mL compared with placebo/tiotropium (1.54 versus 1.37 L, p When Perforomist Inhalation Solution ...

Perforomist(R) Inhalation Solution Data in Patients With Moderate to Severe COPD to Be Presented at the International Conference of the American Thoracic Society

... (shortness of breath) and rescue medication use versus treatment with tiotropium alone. In a second ... in patients with moderate to severe COPD versus treatment with tiotropium alone. This data ... by 192 mL compared with placebo/tiotropium (1.54 versus 1.37 L, p<0.0001). Following treatment, the ...

Amgen Highlights Data to Be Presented at ASCO

... Final STEPP results of prophylactic versus reactive skin toxicity (ST) treatment (tx) for ... study compares the effectiveness of prophylactic versus delayed use of granulocyte colony-stimulating ... agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 ...

Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

... score than those without the disease (46 percent versus 44 percent) More than a ... who have not experienced a fracture (71 percent versus 44 percent). More specifically, those who have ... to avoid carrying heavy objects (44 percent versus 29 percent), avoid activities and hobbies (32 ...